Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nepafenac 0.1% Oph Susp
DRUG
2 trials
Sponsors
University Hospital of Patras
, L.V. Prasad Eye Institute
Conditions
Congenital Hereditary Endothelial Dystrophy of Cornea
Pain
Phase 2
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops
NCT04843839
L.V. Prasad Eye Institute
Congenital Hereditary Endothelial Dystrophy of Cornea
Start: 2020-12-15
End: 2022-12-15
Target: 30
Updated: 2021-04-14
Unknown Phase
Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections
Completed
NCT03406689
University Hospital of Patras
Pain
Start: 2017-09-01
End: 2018-03-28
Updated: 2018-04-04